Showing results (181-190 of 384) with videos related to
Sort By:
Pageof 39
Microscopy Research and Technique|May 1, 1996
Invasive processes in the normal Harderian gland of Syrian hamsterD Tolivia, H Uria, J C Mayo, et al.Journal of the National Cancer Institute|April 19, 2015
Blockade of a key region in the extracellular domain inhibits HER2 dimerization and signalingJavier A Menendez, Barbara Schroeder, Susan K Peirce, et al.Cell Cycle (Georgetown, Tex.)|December 1, 2011
Autophagy positively regulates the CD44(+) CD24(-/low) breast cancer stem-like phenotypeSílvia Cufí, Alejandro Vazquez-Martin, Cristina Oliveras-Ferraros, et al.Aging|June 21, 2012
Mitochondrial fusion by pharmacological manipulation impedes somatic cell reprogramming to pluripotency: new insight into the role of mitophagy in cell stemnessAlejandro Vazquez-Martin, Sílvia Cufi, Bruna Corominas-Faja, et al.Cell Cycle (Georgetown, Tex.)|November 20, 2010
Metformin against TGFβ-induced epithelial-to-mesenchymal transition (EMT): from cancer stem cells to aging-associated fibrosisSilvia Cufí, Alejandro Vazquez-Martin, Cristina Oliveras-Ferraros, et al.Clinical Toxicology (Philadelphia, Pa.)|July 20, 2016
Two cases of intoxication with new synthetic opioid, U-47700K Domanski, K C Kleinschmidt, J M Schulte, et al.Journal of Clinical Medicine|June 11, 2020
Silibinin and SARS-CoV-2: Dual Targeting of Host Cytokine Storm and Virus Replication Machinery for Clinical Management of COVID-19 PatientsJoaquim Bosch-Barrera, Begoña Martin-Castillo, Maria Buxó, et al.Proceedings of the National Academy of Sciences of the United States of America|July 6, 2004
Inhibition of fatty acid synthase (FAS) suppresses HER2/neu (erbB-2) oncogene overexpression in cancer cellsJavier A Menendez, Luciano Vellon, Inderjit Mehmi, et al.Medical Hypotheses|April 30, 2014
Late-emerging strains of HIV induce T-cell homeostasis failure by promoting bystander cell death and immune exhaustion in naïve CD4 and all CD8 T-cellsCatherine N Kibirige, Frederick A Menendez, Hao Zhang, et al.Anticancer Research|July 31, 2014
Silibinin administration improves hepatic failure due to extensive liver infiltration in a breast cancer patientJoaquim Bosch-Barrera, Bruna Corominas-Faja, Elisabet Cuyàs, et al.Pageof 39